Trump Picks Pharma Exec to Run HHS

Worldwide Speakers Group

I had totally forgotten that Tom Price was forced to resign as secretary of HHS because he spent over a million dollars of taxpayer money on private charters and military jets. That means we need a new one. But who?

President Trump nominated a pharmaceutical executive to be the next secretary of the Health and Human Services Department. The nominee, Alex M. Azar II, served as a deputy at the department under former President George W. Bush. Until January, he was the head of the pharmaceutical company Eli Lilly’s United States division.

Mr. Trump made his announcement in a Twitter post while traveling in Asia. Mr. Trump said Mr. Azar would be “a star for better healthcare and lower drug prices!”

I suppose I didn’t have to ask. Of course it was some wealthy Big Pharma guy. Who else would be a champion for lower drug prices, after all?

Look, I really need that all-purpose response to Trump that I asked for in the last post. Let’s get on this, shall we?


Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn't fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation today so we can keep on doing the type of journalism 2019 demands.

We Recommend


Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.


Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.


We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.